Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Acquisition of health equipment within the High-End Technology Equipment Investment Plan in Spain

24 Feb 2022

On January 18, 2022, it was announced that the Ministry of Health, through the National Institute of Health Management (INGESA), has awarded the Framework Agreement for the acquisition of 81 linear accelerators included in the High-End Technology Equipment Investment Plan (INVEAT) promoted by the Government of Spain, as part of Component 18 of the Recovery, Transformation and Resilience Plan.

This Framework Agreement has an investment of €212,761,357.81 (€175,835,832.90 without taxes) and will involve the acquisition of high-tech equipment for the treatment of oncological diseases, by a total of 15 Autonomous Communities, in addition to the Ministry of Defense.

The Framework Agreement includes three lots focused on the acquisition of high-performance linear accelerators, high-energy linear accelerators for adaptive radiation therapy, and linear accelerators for radiosurgery treatments and stereotactic body radiation therapy.

The companies that have been awarded are Ab Salud, S.L, ELEKTA MEDICAL SAU, and Varian Medical Systems Ibérica S.L.

The INGESA has also initiated the processing of the Framework Agreement that will facilitate the acquisition of the equipment in the fields of interventional cardiology, interventional vascular radiology, interventional neurovascular, computed tomography, digital brachytherapy, magnetic resonance imaging, PET-CT, SPECT-CT by the Autonomous Communities and other administrations.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.